Your session is about to expire
← Back to Search
CT Perfusion Imaging for Subarachnoid Hemorrhage (CT-PIPS Trial)
CT-PIPS Trial Summary
This trialwill test if CT scans can predict which SAH patients are at risk of stroke from vasospasm, helping to improve their outcomes.
CT-PIPS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CT-PIPS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are younger than 18 or older than 75 years old.The patient is not expected to live for more than 24 hours, for example, if they have lost certain reflexes or are being considered for organ donation instead of treatment.You are between 18 and 75 years old.You have a documented brain aneurysm that has ruptured.
- Group 1: CT Perfusion
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this clinical trial include participants over 20 years old?
"To be eligible for this trial, participants must fall between the age of 18 and 75. Moreover, there are 94 trials available to minors and 668 specifically catering to those over 65."
Do I fulfill the requirements necessary to join this medical research?
"Qualified applicants to this clinical trial must have a diagnosis of subarachnoid hemorrhage and be between the ages of 18 and 75. The total number of patients that are allowed to take part in the study is capped at 41."
Are there available opportunities for individuals to join this medical trial?
"According to clinicaltrials.gov, this medical trial is not currently recruiting patients; the study was initially published on April 1st 2014 and last modified on February 6th 2023. Despite no longer being open for enrollment, there are still 774 other trials actively seeking participants."
Share this study with friends
Copy Link
Messenger